Transdermal iontophoretic delivery of timolol maleate in albino rabbits

International Journal of Pharmaceutics

Volumn 197, Issue 1-2, 2000, Pages 69-76

  Kanikkannan, N ^a   Singh, J ^b   Ramarao, P ^c  

^a FLORIDA A AND M UNIVERSITY   (United States)

^b NORTH DAKOTA STATE UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Azone ; Iontophoresis; Rabbits; Timolol maleate; Transdermal

Indexed keywords

ISOPRENALINE; LAUROCAPRAM; TIMOLOL MALEATE;

ANIMAL EXPERIMENT; ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG METABOLISM; DRUG SOLUBILITY; IONTOPHORESIS; MOLECULAR SIZE; NONHUMAN; PRIORITY JOURNAL; RABBIT; TACHYCARDIA;

ADMINISTRATION, CUTANEOUS; ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; AREA UNDER CURVE; AZEPINES; EMULSIONS; EXCIPIENTS; HALF-LIFE; INJECTIONS, INTRAVENOUS; IONTOPHORESIS; ISOPROTERENOL; LIVER; RABBITS; SOLUTIONS; TACHYCARDIA; TIMOLOL;

EID: 0033997996     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(99)00457-3     Document Type: Article

References (26)

1. Barry B.W., Williams A.C. Penetration enhancement through skin. Swarbrick J., Boylon J.C. Encyclopedia of Pharmaceutical Technology. 11:1995;449-493 Marcel Dekker, New York.
2. Bhatia K.S., Singh J. Mechanism of transport enhancement of LHRH through porcine epidermis by terpenes and iontophoresis: permeability and lipid extraction studies. Pharm. Res. 15:1998;1857-1862.
3. Bhatia K.S., Singh J. Effect of linolenic acid/ethanol or limonene/ethanol and iontophoresis on the in vivo percutaneous absorption of LHRH and ultrastructure of human epidermis. Int. J. Pharm. 180:1999;235-250.
4. Elgart M.L., Fuchs G. Tap water iontophoresis in the treatment of hyperhidrosis. Int. J. Dermatol. 26:1987;194-197.
5. Ganga S., Ramarao P., Singh J. Effect of Azone on the iontophoretic transdermal delivery of metoprolol tartrate through human epidermis in vitro. J. Control. Release. 42:1996;57-64.
6. Gangarosa L.P., Buettner A.L., Baker B.S., Buettner B.K., Thompson W.O. Double-blind evaluation of duration of dentin sensitivity reduction by fluoride iontophoresis. J. Gen. Dent. 37:1989;316-319.
7. Green P. Iontophoretic delivery of peptide drugs. J. Control. Release. 41:1996;33-48.
8. Green P., Shroot B., Bernerd F., Pilgrim W.R., Guy R.H. In vitro and in vivo iontophoresis of a tripeptide across nude rat skin. J. Control. Release. 20:1992;209-218.
9. Hirvonen J., Kontturi K., Murtomaki L., Paronen P., Uritti A. Transdermal iontophoresis of sotalol and salicylate; the effect of skin charge and penetration enhancers. J. Control. Release. 26:1993;109-117.
10. Hirvonen J., Rajala R., Vihervaara P., Paronen P., Uritti A. et al. Mechanism and reversibility of penetration enhancer action in the skin - DSC study. Eur. J. Pharm. Biopharm. 40:1994;81-85.
11. Hirvonen J., Murtomaki L., Kontturi K. Experimental verification of the mechanistic model for transdermal transport including iontophoresis. J. Control. Release. 56:1998;169-174.
12. Ishizaki T., Tawara K. Comparison of disposition and effect of timolol and propranolol on exercise tachycardia. Eur. J. Clin. Pharmacol. 14:1978;7-14.
13. Jacqueline B., McCrea J.B., Vlasses P.H., Franz T.J., Zeoli L. Transdermal timolol: β blockade and plasma concentrations after application for 48 h and 7 days. Pharmacotherapy. 10:1990;289-293.
14. Kai T., Nakazono M., Kurosaaki Y., Nakayama T., Kimura T. Keratinised epithelial transport of β-blocking agents. III. Evaluation of enhancing effect on percutaneous absorption using model lipid liposomes. Biol. Pharm. Bull. 16:1993;801-805.
15. Kalia Y.N., Guy R.H. Electrical characteristics of human skin in vivo. Pharm. Res. 12:1995;1605-1613.
16. Kalia Y.N., Guy R.H. Interaction between penetration enhancers and iontophoresis: effect on human skin impedance in vivo. J. Control. Release. 44:1997;33-42.
17. Kasting G.B. Theoretical models for iontophoretic delivery. Adv. Drug Del. Rev. 9:1992;177-199.
18. Kemken J., Ziegler A., Muller B.W. Investigations into the pharmacodynamic effects of dermally administered microemulsions containing beta-blockers. J. Pharm. Pharmacol. 43:1991;679-684.
19. Lark M.R., Gangarosa L.P. Iontophoresis: an effective modality for the treatment of inflammatory disorders of the temporomandibular joint and myofascial pain. Cranio. 8:1990;108-119.
20. Panus P., Banga A.K. Iontophoresis devices: clinical applications for topical delivery. Int. J. Pharm. Compounding. 1:1997;420-424.
21. Russo J., Lipman A.G., Comsztock T.J., Page B.C., Stephen R.L. Lidocaine anaesthesia: comparison of iontophoresis, injection and swabbing. Am. J. Hosp. Pharm. 37:1980;843-847.
22. Sage B.H. Iontophoresis. Swarbrick J., Boylan J.C. Encyclopedia of Pharmaceutical Technology. 8:1993;217-247 Marcel Dekker, New York.
23. Soni S., Dixit V.K. Comparison between the iontophoretic and passive transdermal delivery of timolol maleate across the human cadaver skin. Pharmazie. 49:1994;73-74.
24. Srinivasan V., Su M.H., Higuchi W.I., Behl C.R. Iontophoresis of polypeptides: effect of ethanol pretreatment of human skin. J. Pharm. Sci. 79:1990;588-591.
25. Sugibayashi K., Hosoya K., Morimoto Y., Higuchi W.I. Effect of absorption enhancer, Azone, on the transport of 5-fluorouracil across the hairless rat skin. J. Pharm. Pharmacol. 37:1985;578-580.
26. Wearley L., Chien Y.W. Enhancement of in vitro skin permeability of azidothymidine (AZT) via iontophoresis and chemical enhancer. Pharm. Res. 7:1990;34-40.